Background: The introduction of cerebral protection devices with systematic stent placement has changed the nature of carotid artery stenosis treatment, reducing the immediate periprocedural complications and delayed restenosis. Methods: We treated 164 patients with 194 carotid artery stenosis procedures; 92% of them were symptomatic patients. Results: The morbidity rate of our series was 1.03% and the mortality was 1.9%. Conclusions: In the future, carotid stenosis treatment should perhaps be performed as a preventative measure and not used as a cure for full-blown symptoms. This could be effective in reducing the morbidity and mortality rates of this pathology.

Keywords:
Cerebral protection, Carotid angioplasty, Carotid stenosis, Carotid stenting
1.
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445–452.
2.
MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. European Carotid Surgery Trialists’ Collaborative Group. Lancet 1991;337:1235–1243.
3.
Theron J, Courthéoux P, Alachkar F, Bouvard G, Maiza D: New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR Am J Neuroradiol 1990;11:869–874.
4.
Griewing B, Brassel F, Von Smekal U, Al Ahmar MT, Kessler C: Carotid artery stenting in patients at surgical high risk: Clinical and ultrasound findings. Cerebrovasc Dis 2000;10:44–48.
5.
Henry M, Amor M: Cerebral protection and carotid angioplasty; in Henry M, Amor M, Theron J, Roubin GS (eds): Carotid Angioplasty and Stenting. Toulouse, Europa Edition, 1998, pp 217–226.
6.
Theron J, Monteiro G, Guimaraens L, Sales S, Coskun O, Sola T, Martin JB, Rüfenacht DA: Practical guide to current technique of ‘protected’ angioplasty and stenting of the carotid bifurcation; in Henry M, Amor M, Theron J, Roubin GS (eds): Carotid Angioplasty and Stenting. Toulouse, Europa Edition, 1998, pp 227–241.
7.
Martin JB, Pache JC, Treggiari M, Puget E, Radü EW, Pizzolato G, Guimaraens L, Theron J, Rüfenacht DA: Quantification of embolic plaque debris retrieved during carotid stenting procedures; in Henry M, Amor M, Theron J, Roubin GS (eds): Carotid Angioplasty and Stenting. Toulouse, Europa Edition, 1998, pp 211–216.
8.
Sugiu K, Martin JB, Pache JC, Guimaraens L, Theron J, Rüfenacht DA: Distal flow protection during carotid stenting. Interv Neuroradiol 1999;5(suppl 1).
9.
Ohki T, Marin ML, Lyon RT, Berdejo GL, Soundararajan K, Ohki M, Yuan JG, Faries PL, Wain RA, Sanchez LA, Suggs WD, Veith FJ: Ex vivo human carotid artery bifurcation stenting correlation of lesion characteristics with embolic potential. J Vasc Surg 1998;27:463–471.
10.
Yadav JS, Roubin GS, King P, Iyer S, Vitek J: Angioplasty and stenting for restenosis after carotid endarterectomy. Stroke 1996;27:2075–2079.
11.
Theron JG, Payelle GG, Coskun O, Huet HF, Guimaraens L: Carotid artery stenosis: Treatment with protected balloon angioplasty and stent placement. Radiology 1996;201:627–636.
12.
Gil Peralta A, Mayol A, González Marcos J, González A, Ruano J, Boza F, Durán F: Percutaneous transluminal angioplasty of the symptomatic atherosclerotic carotid arteries. Stroke 1996;27:2271–2273.
13.
Theron J, Guimaraens L, Coskun O, Sola T, Martin JB, Rüfenacht DA: Complications of carotid angioplasty and stenting; in Henry M, Amor M, Theron J, Roubin GS (eds): Carotid Angioplasty and Stenting. Toulouse, Europa Edition, 1998, pp 287–300.
14.
Among Y, Paulsen R, Marcellus MC, Steinberg G, Marks M: Long-term outcomes after carotid stent placement for treatment of carotid artery dissection. Neurosurgery 1999;45:1368–1374.
15.
Theron J, Nelson M, Alanchkar F, Maiza D: Dynamic digitized cerebral parenchymography. Neuroradiology 1992;34:361–364.
16.
Theron J, Coskun O, Huet H, Oliveira G, Toulas P, Payelle G: Local intraarterial thrombolysis in the carotid territory. Interv Neuroradiol 1996;2:111–126.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.